SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.56 HKD | +3.70% |
|
+9.80% | -13.85% |
| Apr. 25 | Sihuan Pharma Unit Wins Bid to Supply Insulin Products to Chinese Government | MT |
| Mar. 29 | Sihuan Pharmaceutical Narrows 2023 Loss on Absence of Asset, Investment Impairments | MT |
ETFs positioned on Sihuan Pharmaceutical Holdings Group Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.42% | 4 M€ | -27.92% | ||
| 0.01% | 117 M€ | +1.11% | - | |
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 7 M€ | +1.95% | - | |
| 0.00% | 34 M€ | +2.14% | - |
Sihuan Pharmaceutical Holdings Group Ltd is a holding company mainly engaged in pharmaceutical manufacturing business. The Company operates three segments. Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. Innovative Medicine and Other Medicine segment is engaged in the research and development of innovative drugs in the fields of digestion, oncology, non-alcoholic hepatitis, diabetes and complications. The Company also operates Generic Medicine segment.
Sector
Pharmaceuticals
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.56
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.85% | 664M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 460 Stock
- Funds and ETFs Sihuan Pharmaceutical Holdings Group Ltd.
